Literature DB >> 21666835

PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Min Qian1, Susan A Murphy.   

Abstract

Because many illnesses show heterogeneous response to treatment, there is increasing interest in individualizing treatment to patients [11]. An individualized treatment rule is a decision rule that recommends treatment according to patient characteristics. We consider the use of clinical trial data in the construction of an individualized treatment rule leading to highest mean response. This is a difficult computational problem because the objective function is the expectation of a weighted indicator function that is non-concave in the parameters. Furthermore there are frequently many pretreatment variables that may or may not be useful in constructing an optimal individualized treatment rule yet cost and interpretability considerations imply that only a few variables should be used by the individualized treatment rule. To address these challenges we consider estimation based on l(1) penalized least squares. This approach is justified via a finite sample upper bound on the difference between the mean response due to the estimated individualized treatment rule and the mean response due to the optimal individualized treatment rule.

Entities:  

Year:  2011        PMID: 21666835      PMCID: PMC3110016          DOI: 10.1214/10-AOS864

Source DB:  PubMed          Journal:  Ann Stat        ISSN: 0090-5364            Impact factor:   4.028


  15 in total

1.  Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials.

Authors:  Jared K Lunceford; Marie Davidian; Anastasios A Tsiatis
Journal:  Biometrics       Date:  2002-03       Impact factor: 2.571

2.  A Generalization Error for Q-Learning.

Authors:  Susan A Murphy
Journal:  J Mach Learn Res       Date:  2005-07       Impact factor: 3.654

3.  Personalized medicine: elusive dream or imminent reality?

Authors:  L J Lesko
Journal:  Clin Pharmacol Ther       Date:  2007-06       Impact factor: 6.875

4.  Estimation and extrapolation of optimal treatment and testing strategies.

Authors:  James Robins; Liliana Orellana; Andrea Rotnitzky
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

5.  Evaluating subject-level incremental values of new markers for risk classification rule.

Authors:  T Cai; L Tian; D Lloyd-Jones; L J Wei
Journal:  Lifetime Data Anal       Date:  2013-06-27       Impact factor: 1.588

6.  Marginal Mean Models for Dynamic Regimes.

Authors:  S A Murphy; M J van der Laan; J M Robins
Journal:  J Am Stat Assoc       Date:  2001-12-01       Impact factor: 5.033

7.  Calibrating parametric subject-specific risk estimation.

Authors:  T Cai; L Tian; Hajime Uno; Scott D Solomon; L J Wei
Journal:  Biometrika       Date:  2010-06       Impact factor: 2.445

8.  Evaluating multiple treatment courses in clinical trials.

Authors:  P F Thall; R E Millikan; H G Sung
Journal:  Stat Med       Date:  2000-04-30       Impact factor: 2.373

9.  An independently derived and validated predictive model for selecting patients with myocardial infarction who are likely to benefit from tissue plasminogen activator compared with streptokinase.

Authors:  David M Kent; Rodney A Hayward; John L Griffith; Sandeep Vijan; Joni R Beshansky; Robert M Califf; Harry P Selker
Journal:  Am J Med       Date:  2002-08-01       Impact factor: 4.965

10.  A statistical model for predicting response of breast cancer patients to cytotoxic chemotherapy.

Authors:  M L Feldstein; E D Savlov; R Hilf
Journal:  Cancer Res       Date:  1978-08       Impact factor: 12.701

View more
  128 in total

1.  A Simple Method for Estimating Interactions between a Treatment and a Large Number of Covariates.

Authors:  Lu Tian; Ash A Alizadeh; Andrew J Gentles; Robert Tibshirani
Journal:  J Am Stat Assoc       Date:  2014-10       Impact factor: 5.033

2.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

3.  Tree based weighted learning for estimating individualized treatment rules with censored data.

Authors:  Yifan Cui; Ruoqing Zhu; Michael Kosorok
Journal:  Electron J Stat       Date:  2017-10-18       Impact factor: 1.125

4.  Semiparametric Single-Index Model for Estimating Optimal Individualized Treatment Strategy.

Authors:  Rui Song; Shikai Luo; Donglin Zeng; Hao Helen Zhang; Wenbin Lu; Zhiguo Li
Journal:  Electron J Stat       Date:  2017       Impact factor: 1.125

5.  Learning Optimal Personalized Treatment Rules in Consideration of Benefit and Risk: with an Application to Treating Type 2 Diabetes Patients with Insulin Therapies.

Authors:  Yuanjia Wang; Haoda Fu; Donglin Zeng
Journal:  J Am Stat Assoc       Date:  2017-03-31       Impact factor: 5.033

6.  TARGETED SEQUENTIAL DESIGN FOR TARGETED LEARNING INFERENCE OF THE OPTIMAL TREATMENT RULE AND ITS MEAN REWARD.

Authors:  Antoine Chambaz; Wenjing Zheng; Mark J van der Laan
Journal:  Ann Stat       Date:  2017-12-15       Impact factor: 4.028

7.  Evaluating marker-guided treatment selection strategies.

Authors:  Roland A Matsouaka; Junlong Li; Tianxi Cai
Journal:  Biometrics       Date:  2014-04-29       Impact factor: 2.571

8.  Learning Personalized Treatment Rules from Electronic Health Records Using Topic Modeling Feature Extraction.

Authors:  Peng Wu; Tianchen Xu; Yuanjia Wang
Journal:  Proc Int Conf Data Sci Adv Anal       Date:  2020-01-23

9.  A single-index model with multiple-links.

Authors:  Hyung Park; Eva Petkova; Thaddeus Tarpey; R Todd Ogden
Journal:  J Stat Plan Inference       Date:  2019-07-04       Impact factor: 1.111

10.  Deep Reinforcement Learning for Dynamic Treatment Regimes on Medical Registry Data.

Authors:  Ying Liu; Brent Logan; Ning Liu; Zhiyuan Xu; Jian Tang; Yanzhi Wang
Journal:  Healthc Inform       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.